WHO suspends Anuh Pharma’s two products from prequalified list

22 Apr 2016 Evaluate

The World Health Organisation (WHO) has suspended Anuh Pharma’s products -- Pyrazinamide and Sulfadoxine from prequalified list of active pharmaceutical ingredients (API). Pre-qualification is a process under which drug companies have to fulfil certain WHO-stipulated conditions to become eligible to supply vaccines to UN procurement agencies globally.

The WHO's move comes in the wake of European Directorate for the Quality of Medicines and Healthcare (EQDM) suspending certificate of suitability for the drug firm's three products last month after conducting an inspection of its manufacturing site at Boisar in Maharashtra.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma Share Price

82.55 3.39 (4.28%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×